Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular protein metabolic process" refers to the entirety of biochemical reactions related to the synthesis, modification, and degradation of proteins within cells. This includes the translation of amino acids into polypeptides, post-translational modifications (such as phosphorylation, ubiquitination, methylation, acetylation, glycosylation), and the breakdown of proteins via systems like the ubiquitin-proteasome pathway. These processes are essential for cellular homeostasis, signal transduction, and adaptation to environmental changes. Dysregulation of protein metabolic processes contributes to a wide range of diseases, including cancer, metabolic and neurodegenerative disorders. However, "cellular protein metabolic process" is not a druggable target as such, but rather an umbrella term for numerous enzymatic and regulatory systems involved in protein metabolism[4][5][7]. This entry is classified as incorrect as a molecular drug target because it is not specific—it encompasses many enzymes, transporters, and pathways, rather than a distinct molecular entity or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular protein metabolic process.